About Motor neuron and pancreas homeobox protein 1
Motor neuron and pancreas homeobox protein 1 (MNX1) is a protein
from Homo sapiens identified by UniProt accession
P50219, 401 residues long.
MolForge cross-references it against 0 known binders and
230 disease associations.
Target properties
| Protein name | Motor neuron and pancreas homeobox protein 1 |
| UniProt accession | P50219 |
| Gene | MNX1 |
| Organism | Homo sapiens |
| Length | 401 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (230)
Diseases linked to this target (Open Targets).
- Currarino triad · score 0.80
- permanent neonatal diabetes mellitus · score 0.37
- neonatal diabetes mellitus · score 0.37
- anorectal malformation · score 0.37
- protein measurement · score 0.21
- non-small cell lung carcinoma · score 0.21
- hepatocellular carcinoma · score 0.21
- urinary bladder carcinoma · score 0.21
- lung adenocarcinoma · score 0.20
- colon adenocarcinoma · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P50219-F1 | alphafold | PREDICTED | 57.12 | — |
Amino-acid sequence (401 residues)
MEKSKNFRID ALLAVDPPRA ASAQSAPLAL VTSLAAAASG TGGGGGGGGA SGGTSGSCSP ASSEPPAAPA DRLRAESPSP PRLLAAHCAL LPKPGFLGAG GGGGGTGGGH GGPHHHAHPG AAAAAAAAAA AAAAGGLALG LHPGGAQGGA GLPAQAALYG HPVYGYSAAA AAAALAGQHP ALSYSYPQVQ GAHPAHPADP IKLGAGTFQL DQWLRASTAG MILPKMPDFN SQAQSNLLGK CRRPRTAFTS QQLLELEHQF KLNKYLSRPK RFEVATSLML TETQVKIWFQ NRRMKWKRSK KAKEQAAQEA EKQKGGGGGA GKGGAEEPGA EELLGPPAPG DKGSGRRLRD LRDSDPEEDE DEDDEDHFPY SNGASVHAAS SDCSSEDDSP PPRPSHQPAP Q
Explore Motor neuron and pancreas homeobox protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets